Phase
Condition
Hernia
Treatment
N/AClinical Study ID
Ages 18-90 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
BMI (Body mass index) < 30
Non severe liver, renal or cardiac disease
No allergy or contraindications to any of the study drugs
American Hernia Society Score type I-II-IV-V hernia
No pain or chronic analgesic administration in the preoperative period
No previous surgery of the inguinal region
Normal coagulation parameters and platelet count (> 100.000).
Dicumarol and aspirin suspension for > 7 days
Correctly administrated premedication
No systemic infections
No contraindications to subarachnoid anesthesia
Exclusion
Exclusion Criteria:
BMI (Body mass index) > 30
Severe liver, renal or cardiac disease
Allergy or contraindications to any of the study drugs
American Hernia Society Score type III-VI-VII-0 hernia
Pain or chronic analgesic administration in the preoperative period
Previous surgery of the inguinal region
Anormal coagulation parameters and platelet count (< 100.000).
No dicumarol and aspirin suspension for > 7 days
Incorrectly administrated premedication
Systemic infections
Contraindications to subarachnoid anesthesia
Study Design
Study Description
Connect with a study center
San Gerardo Hospital
Monza, 20900
ItalySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.